BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 15964866)

  • 1. Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old.
    Geijer RM; Sachs AP; Hoes AW; Salomé PL; Lammers JW; Verheij TJ
    Fam Pract; 2005 Oct; 22(5):485-9. PubMed ID: 15964866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender and chronic obstructive pulmonary disease in high-risk smokers.
    de Torres JP; Campo A; Casanova C; Aguirre-Jaime A; Zulueta J
    Respiration; 2006; 73(3):306-10. PubMed ID: 16330871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and determinants of moderate COPD (GOLD II) in male smokers aged 40-65 years: 5-year follow up.
    Geijer RM; Sachs AP; Verheij TJ; Salomé PL; Lammers JW; Hoes AW
    Br J Gen Pract; 2006 Sep; 56(530):656-61. PubMed ID: 16953996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Farming and the prevalence of non-reversible airways obstruction: results from a population-based study.
    Lamprecht B; Schirnhofer L; Kaiser B; Studnicka M; Buist AS
    Am J Ind Med; 2007 Jun; 50(6):421-6. PubMed ID: 17497693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel.
    Stav D; Raz M
    Isr Med Assoc J; 2007 Nov; 9(11):800-2. PubMed ID: 18085037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FEV1/FVC and FEV1 for the assessment of chronic airflow obstruction in prevalence studies: do prediction equations need revision?
    Roche N; Dalmay F; Perez T; Kuntz C; Vergnenègre A; Neukirch F; Giordanella JP; Huchon G
    Respir Med; 2008 Nov; 102(11):1568-74. PubMed ID: 18657959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC.
    Fukahori S; Matsuse H; Takamura N; Hirose H; Tsuchida T; Kawano T; Fukushima C; Mizuta Y; Kohno S
    Int J Clin Pract; 2009 Feb; 63(2):269-74. PubMed ID: 19196365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?
    Medbø A; Melbye H
    Respir Med; 2007 Jun; 101(6):1097-105. PubMed ID: 17239575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of forced expiratory volume in one second (FEV1) among asymptomatic smokers and non-smokers.
    Khan A; Shabbir K; Ansari JK; Zia N
    J Pak Med Assoc; 2010 Mar; 60(3):209-13. PubMed ID: 20225780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COPD in Japan: the Nippon COPD Epidemiology study.
    Fukuchi Y; Nishimura M; Ichinose M; Adachi M; Nagai A; Kuriyama T; Takahashi K; Nishimura K; Ishioka S; Aizawa H; Zaher C
    Respirology; 2004 Nov; 9(4):458-65. PubMed ID: 15612956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spirometric and anthropometric determinants of forced expiratory time in a general population.
    Kainu A; Lindqvist A; Sarna S; Sovijärvi A
    Clin Physiol Funct Imaging; 2008 Jan; 28(1):38-42. PubMed ID: 18171402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of spirometry in primary care for case finding of airway obstruction in smokers.
    Leuppi JD; Miedinger D; Chhajed PN; Buess C; Schafroth S; Bucher HC; Tamm M
    Respiration; 2010; 79(6):469-74. PubMed ID: 19786731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-reversible airway obstruction in never smokers: results from the Austrian BOLD study.
    Lamprecht B; Schirnhofer L; Kaiser B; Buist S; Studnicka M
    Respir Med; 2008 Dec; 102(12):1833-8. PubMed ID: 18722100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are patient characteristics helpful in recognizing mild COPD (GOLD I) in daily practice?
    Geijer RM; Sachs AP; Verheij TJ; Lammers JW; Salomé PL; Hoes AW
    Scand J Prim Health Care; 2006 Dec; 24(4):237-42. PubMed ID: 17118864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.
    Johannessen A; Omenaas ER; Bakke PS; Gulsvik A
    Thorax; 2005 Oct; 60(10):842-7. PubMed ID: 16085729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.
    Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF
    Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airway obstruction in never smokers: results from the Third National Health and Nutrition Examination Survey.
    Celli BR; Halbert RJ; Nordyke RJ; Schau B
    Am J Med; 2005 Dec; 118(12):1364-72. PubMed ID: 16378780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Early detection of COPD in smokers from Warsaw using spirometric screening].
    Bednarek M; Pływaczewski R; Górecka D; Puścińska E; Nowiński A; Zieliński J
    Pneumonol Alergol Pol; 2002; 70(3-4):139-47. PubMed ID: 12271961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of airway obstruction in recreational SCUBA divers.
    Weaver LK; Churchill SK; Hegewald MJ; Jensen RL; Crapo RO
    Wilderness Environ Med; 2009; 20(2):125-8. PubMed ID: 19594212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking Report from the Obstructive Lung Disease in Northern Sweden Studies.
    Lindberg A; Bjerg A; Rönmark E; Larsson LG; Lundbäck B
    Respir Med; 2006 Feb; 100(2):264-72. PubMed ID: 15975774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.